Page last updated: 2024-10-15

phosphoserine and Acquired Nephrogenic Diabetes Insipidus

phosphoserine has been researched along with Acquired Nephrogenic Diabetes Insipidus in 1 studies

Phosphoserine: The phosphoric acid ester of serine.

Research Excerpts

ExcerptRelevanceReference
"Heritable nephrogenic diabetes insipidus (NDI) is characterized by defective urine concentration mechanisms in the kidney, which are mainly caused by loss-of-function mutations in the vasopressin type 2 receptor."1.43Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway. ( Ando, F; Kikuchi, E; Kondo, Y; Mori, T; Morimoto, T; Nomura, N; Rai, T; Sasaki, S; Sohara, E; Takahashi, D; Uchida, S; Vandewalle, A; Yui, N, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, F1
Sohara, E1
Morimoto, T1
Yui, N1
Nomura, N1
Kikuchi, E1
Takahashi, D1
Mori, T1
Vandewalle, A1
Rai, T1
Sasaki, S1
Kondo, Y1
Uchida, S1

Other Studies

1 other study available for phosphoserine and Acquired Nephrogenic Diabetes Insipidus

ArticleYear
Wnt5a induces renal AQP2 expression by activating calcineurin signalling pathway.
    Nature communications, 2016, 11-28, Volume: 7

    Topics: Animals; Aquaporin 2; Arachidonic Acid; beta Catenin; Calcineurin; Calcium; Calcium Signaling; Cycli

2016